ARID1A and pancreatic neoplasm: However, despite this relatively low frequency of genetic alterations, three independent studies of ARID1A protein abundance in pancreatic cancer tissue samples have reported lost or reduced ARID1A expression in 26%, 36%, and 51% of cases [103,104,105].